Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589
Epidemiology and natural history of chronic Hepatitis B in the Canadian province of Alberta from 2012 to 2021: A population-based study
Golasa Samadi Kochaksaraei; Fengjuan Yang; Cynthia H. Seow; Herman W Barkema; Carla S Coffin; Abdel-Aziz Shaheen;
10.1016/j.aohep.2024.101576
cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B
Patricia Gita Naully; Marselina Irasonia Tan; Agustiningsih Agustiningsih; Caecilia Sukowati; Ernawati Arifin Giri-Rachman;
10.1016/j.aohep.2024.101533